insulin sensitivity enhancers (Hager)

N/A

Report date: 2025/03/20 15:58:36
NME

Base Information

Drug Nameinsulin sensitivity enhancers (Hager)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHager Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesHager Biosciences LLC
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A